366 related articles for article (PubMed ID: 28158993)
21. [Minimal change disease and focal segmental glomerulosclerosis in children--histomorphometric comparative study with application to computer image analysis].
Danilewicz M; Wagrowska-Danilewicz M
Przegl Lek; 1996; 53(7):529-33. PubMed ID: 8975287
[TBL] [Abstract][Full Text] [Related]
22. Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response.
Park CW; Song HC; Shin YS; Ahn SJ; Kim YS; Kim SY; Choi EJ; Chang YS; Bang BK
Nephron; 1998; 79(1):44-9. PubMed ID: 9609461
[TBL] [Abstract][Full Text] [Related]
23. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[TBL] [Abstract][Full Text] [Related]
24. Reduced INF2 expression in nephrotic syndrome is possibly related to clinical severity of steroid resistance in children.
Tamura H; Nakazato H; Kuraoka S; Yoneda K; Takahashi W; Endo F
Nephrology (Carlton); 2016 Jun; 21(6):467-75. PubMed ID: 26383224
[TBL] [Abstract][Full Text] [Related]
25. Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis.
Wagrowska-Danilewicz M; Danilewicz M
Nefrologia; 2007; 27(6):710-5. PubMed ID: 18336100
[TBL] [Abstract][Full Text] [Related]
26. Urinary low-molecular-weight protein excretion in pediatric idiopathic nephrotic syndrome.
Chehade H; Parvex P; Poncet A; Werner D; Mosig D; Cachat F; Girardin E
Pediatr Nephrol; 2013 Dec; 28(12):2299-306. PubMed ID: 23949592
[TBL] [Abstract][Full Text] [Related]
27. Proteomic Analysis of Idiopathic Nephrotic Syndrome Triggered by Primary Podocytopathies in Adults: Regulatory Mechanisms and Diagnostic Implications.
Chen Q; Xu J; Liu L; Ye Q; Lin W; Liao Y; Gao R; Zhang X; Chen R; Xiong Y; Chen S; Ye X; Wei L
J Proteome Res; 2024 Jun; 23(6):2090-2099. PubMed ID: 38728052
[TBL] [Abstract][Full Text] [Related]
28. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
[TBL] [Abstract][Full Text] [Related]
29. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
Voznesenskaia TS; Sergeeva TV
Ter Arkh; 2002; 74(6):31-3. PubMed ID: 12136479
[TBL] [Abstract][Full Text] [Related]
30. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
[TBL] [Abstract][Full Text] [Related]
31. The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.
Minamikawa S; Nozu K; Maeta S; Yamamura T; Nakanishi K; Fujimura J; Horinouchi T; Nagano C; Sakakibara N; Nagase H; Shima H; Noda K; Ninchoji T; Kaito H; Iijima K
Sci Rep; 2018 Nov; 8(1):17322. PubMed ID: 30470792
[TBL] [Abstract][Full Text] [Related]
32. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
33. Distinct urinary lipid profile in children with focal segmental glomerulosclerosis.
Erkan E; Zhao X; Setchell K; Devarajan P
Pediatr Nephrol; 2016 Apr; 31(4):581-8. PubMed ID: 26537928
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of C4d expression and staining patterns by immunohistochemistry in renal biopsy samples with focal segmental glomerulosclerosis and minimal change disease.
Abedi M; Nili F; Dehkhoda F; Abdollahi A; Salarvand S
Ann Diagn Pathol; 2024 Jun; 70():152281. PubMed ID: 38417352
[TBL] [Abstract][Full Text] [Related]
35. Urinary proteins from patients with nephrotic syndrome alters the signalling proteins regulating epithelial-mesenchymal transition.
Wen Q; Huang Z; Zhou SF; Li XY; Luo N; Yu XQ
Nephrology (Carlton); 2010 Feb; 15(1):63-74. PubMed ID: 20377773
[TBL] [Abstract][Full Text] [Related]
36. Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosis.
Kuo HT; Kuo MC; Chiu YW; Chang JM; Guh JY; Chen HC
Eur J Clin Invest; 2005 Apr; 35(4):245-50. PubMed ID: 15816993
[TBL] [Abstract][Full Text] [Related]
37. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
[TBL] [Abstract][Full Text] [Related]
38. Minimal change disease and idiopathic FSGS: manifestations of the same disease.
Maas RJ; Deegens JK; Smeets B; Moeller MJ; Wetzels JF
Nat Rev Nephrol; 2016 Dec; 12(12):768-776. PubMed ID: 27748392
[TBL] [Abstract][Full Text] [Related]
39. Angiopoietin-like-4 and minimal change disease.
Cara-Fuentes G; Segarra A; Silva-Sanchez C; Wang H; Lanaspa MA; Johnson RJ; Garin EH
PLoS One; 2017; 12(4):e0176198. PubMed ID: 28441404
[TBL] [Abstract][Full Text] [Related]
40. Childhood minimal change disease and focal segmental glomerulosclerosis: a continuous spectrum of disease? Pathologic study of 33 cases with long-term follow-up.
Lichtig C; Ben-Izhak O; On A; Levy J; Allon U
Am J Nephrol; 1991; 11(4):325-31. PubMed ID: 1799192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
